Reproduction Fertility and Development · 1995 · 45 citations · 20 references
Veterinary MedicineVeterinary Clinical SciencesEquine MedicineEquine ScienceIn Vitro FertilizationBlastocyst DevelopmentEmbryo CultureEmbryo EvaluationEmbryo HandlingEmbryo Viability AssessmentEmbryo VitrificationBlastocyst PreservationBlastocyst VitrificationOsmotic PressureThawing Of Vitrified EmbryosThawing Of Vitrified OocytesVitrificationZona Pellucida ChangesZona Pellucida Damage
Viability following vitrification of equine blastocysts with different sizes was investigated in vitro. Twenty-four blastocysts were classified into three groups according to their diameters (< 200 microns, 200-300 microns and > 300 microns; n = 8 each). The solution used for vitrification was defined as EFS and contained 40% ethylene glycol, 18% Ficoll and 0.3 M sucrose in modified-phosphate-buffered saline (m-PBS). During pretreatment with 20% ethylene glycol in m-PBS for 20 min, the larger blastocysts responded to the osmotic pressure caused by 20% ethylene glycol more slowly than the smaller blastocysts. Single blastocysts were loaded into the EFS in 0.25-mL straws, left to stand for 1 min and vitrified in nitrogen vapour. After thawing for 20 s in water (20 degrees C), a fractured zona pellucida or capsule was seen in: 1 of 8 blastocysts < 200 microns in diameter; 1 of 8 blastocysts 200-300 microns in diameter; and 2 of 8 blastocysts > 300 microns in diameter. When the blastocysts were cultured for 48 h in TCM199 supplemented with 10% fetal bovine serum at 37 degrees C in 5% CO2 in air, 7 of 8 (88%) blastocysts < 200 microns in diameter and 6 of 8 (75%) blastocysts 200-300 microns in diameter developed with re-expansion of the blastocoele. However, the developmental ability of blastocysts > 300 microns in diameter (2 of 8, 25%) was significantly lower than that of blastocysts < 200 microns in diameter (P < 0.05).
20
Magosaburo Kasai, J. H. Komi, A. Takakamo et al. · Reproduction · 1990 · 374 citations · Full text
Veterinary Medicine, Developmental Biology, Assisted Reproductive Technologies +16